Related Experiment Videos
Disulfiram induced reversible hypertension: a prospective case study and brief review
Ranganath R Kulkarni1, Bhavya K Bairy
1Department of Psychiatry, SDM College of Medical Sciences and Hospital, Dharwad, Karnataka, India.
Abstract:
Disulfiram (DSF) is one of the recommended aids in the management of alcohol dependence. Hypertension may be a clinically significant, dose-dependent, and usually reversible adverse event of DSF therapy. We report 6 month prospective study of normotensive case of comorbid alcohol and tobacco dependence that developed reversible stage-II hypertension within 2-4 weeks of DSF therapy. We suggest that regular monitoring of blood pressure at least fortnightly for 1(st) 3 months, followed by monthly for next 3 months, and later once in 3 months, may possibly detect "silent" adverse event of DSF - hypertension.
Related Concept Videos
Antihypertensive Drugs: Thiazide-Class Diuretics
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Toxicity: Risk factors
Hypertension III: Clinical Manifestations and Diagnostic Studies
CNS Depressants: Alcohol and Nicotine